DonaldMO'RourkeMD
Neurosurgery • Philadelphia, PABrain & Spinal Tumor
Associate Professor, Neurosurgery, University of Pennsylvania School of Medicine
Dr. O'Rourke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Fl 3
Philadelphia, PA 19104Phone+1 215-662-3487Fax+1 215-349-5534
Education & Training
University of Pennsylvania Health SystemResidency, Neurological Surgery, 1988 - 1994
Perelman School of Medicine at the University of PennsylvaniaClass of 1987
Certifications & Licensure
PA State Medical License 1988 - 2026
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma Start of enrollment: 2014 Nov 18
- Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies Start of enrollment: 2016 May 23
- CART-EGFRvIII + Pembrolizumab in GBM Start of enrollment: 2019 Mar 11
Publications & Presentations
PubMed
- 11 citationsMRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas.Seyyed Ali Hosseini, Elahe Hosseini, Ghasem Hajianfar, Isaac Shiri, Stijn Servaes
Cancers. 2023-02-02 - 1 citationsCorrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.Benjamin Lin, Julia Ziebro, Erin Smithberger, Kasey R Skinner, Eva Zhao
Neuro-Oncology. 2023-01-05 - 6 citationsRisk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.Lauren Reed-Guy, Arati S Desai, Richard E Phillips, Desiree Croteau, Karen Albright
Neuro-Oncology. 2022-12-01
Press Mentions
New Penn Medicine Center Brings Immunotherapy Research to Brain Tumor TreatmentOctober 30th, 2018
Dual-Target Cell Therapy Shrinks Brain Tumors: Penn MedMarch 19th, 2024
Grant Support
- Credentialing next-generation human glioma models for precision therapeuticsUNIVERSITY OF ALABAMA AT BIRMINGHAM2022–2026
- Credentialing next-generation human glioma models for precision therapeuticsUNIVERSITY OF ALABAMA AT BIRMINGHAM2022–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
